Alpha DNA Investment Management’s Freeport-McMoran FCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-228
Closed -$6K 289
2021
Q1
$6K Buy
+228
New +$7.39K 0.01% 333

Other funds holding FCX

Alpha DNA Investment Management's FCX Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of Freeport-McMoran (FCX) in Q2 2021, closing a stake of 228 shares — an estimated $6K sold.

Alpha DNA Investment Management first reported a position in FCX in Q1 2021 and held it in 1 quarter. The position peaked at $6K in Q1 2021. 1,104 funds tracked by Wall St. Rank hold FCX as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining Freeport-McMoran position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 228 Freeport-McMoran shares in Q2 2021, an estimated $6K.
  • Alpha DNA Investment Management first reported a position in Freeport-McMoran in Q1 2021 and held it in 1 quarter.
  • Alpha DNA Investment Management's Freeport-McMoran position peaked at $6K in Q1 2021.
  • 1,104 funds tracked by Wall St. Rank held Freeport-McMoran as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.